Sources and supplies commercial drug product for global clinical trials today: Project Management – ClientPharma’s clinical trial Project Management team brings proficiency in management and mitigation of risks. You can say goodbye to issues and delays and hello to peace-of-mind. Warehousing and Distribution – ClientPharma handles the numerous challenges of obtaining medicines quickly, in multiple lots, with ranging expiry dating—and we can do this, procuring from any region in the world. To learn more about how we can improve your clinical trial supply experience or receive a quote, please feel free to get in touch. Read more details at accurate pharmaceutical supply.
ClientPharma is licensed and follows regulatory directives and guidelines, complying with Good Distribution Practice (GDP) for Medicines for Human Use, 2013/C 343/01. Our Quality Department is responsible for vigorously maintaining the quality and integrity of your products through our comprehensive Quality Management System. Continuous focus and commitment to quality assures compliance across the board — for the client, for the regulatory agencies, and most importantly, for the patient.
Unbeatable global access to commercial drug products – Unlike many comparator drug sourcing companies, our ethos is to challenge the norms and adapt to your specific needs. We understand the complexities and challenges of multi-faceted projects with time and temperature specifics. Using a combined understanding of your clinical requisites and our extensive knowledge of the commercial market landscape, we work to design a supply strategy unique to your needs. Ask our team for a customized product supply assessment.
On May 20th, we celebrate International Clinical Trials Day 2023. It is a day to reflect on the ground-breaking work and significant contributions of clinical trials in advancing medical research, improving patient care and transforming lives worldwide. Our heartfelt gratitude goes out to the patients participating in clinical trials and we extend our appreciation to all those that make the clinical trials possible; the researchers, physicians, nurses, and healthcare professionals, with their unwavering dedication to bring new and innovative treatments to those in need. Together we can shape the future of medicine and make a lasting impact on the lives of millions. Happy International Clinical Trials Day! See even more information on https://www.clientpharma.com/.
Meeting the needs of global clinical supply trials requires diversity in supply strategies to address the unique complexities of each country’s healthcare and medication distribution systems. The “one-size fits all” approach is not a single supply strategy; instead, it leverages the expertise of a supply vendor partnership that addresses the need for a multi-faceted supply chain strategy. Jeff Wiltrout, Ph.D., Senior Vice President of Business Development at TrialCard, stated, “The responsibilities of clinical trial supply and operations personnel are vast and intricate. They need partners that make complex tasks simple and efficient. The partnership between market leaders like TrialCard and ClientPharma simplifies our clients’ global commercial drug sourcing responsibilities by providing a variety of streamlined, agile and efficient processes.”
Forecasts by their very definition involve a degree of uncertainty. When a company fails to meet demand it can have major implications on the drug and the pharmaceutical company. The company may experience loss in sales, a bad reputation for unreliability with customers and overworked employees. It has been reported that where the drug itself is concerned, if the launch of a medicine is delayed due to a failure in estimation, it costs on average $15 million per drug, per day. Further research has also shown that a blockbuster drug will lose $1 billion in revenue annually until capacity is developed to meet demand. Overestimations in demand generally happen when the market is at its most volatile, or, if the reach of a new drug has been over estimated. These inaccuracies can cost companies. If a product’s demand is overestimated, companies have to find ways to correct their misjudgement by cutting the price of medicines which reduces margins and by making employees redundant to pay for the excess of stock. In some cases companies also have to destroy stock that has not been sold.